One case study found a novel mutation in CPT II (del1737C), an autosomal recessive disease with a distinct phenotype [49]
This is not because KLOW's intrinsic stability changes, but because elimination pathways become temporarily saturated
(PubMed) Tarantini G, Scrutinio D, Bruzzi P, Boni L, Rizzon P, Iliceto S
Care should be individualised if side effects occur, considering impact and potential risks, with ongoing side effects balanced against indication and benefit of GLP-1 and GIP therapy
ease of use
The introduction of GLP-1 therapeutics has revolutionized the treatment of type 2 diabetes and obesity, with other potential indications under investigation